GEODE CAPITAL MANAGEMENT, LLC - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 54 filers reported holding UNUM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$230,000
+597.0%
98,621
+34.3%
0.00%
Q2 2020$33,000
+10.0%
73,4540.0%0.00%
Q1 2020$30,000
-71.2%
73,454
-50.0%
0.00%
Q4 2019$104,000
-1.0%
146,908
+100.0%
0.00%
Q3 2019$105,000
-45.6%
73,454
-0.6%
0.00%
Q2 2019$193,000
-68.9%
73,882
-47.8%
0.00%
Q1 2019$621,000
-46.7%
141,653
-46.6%
0.00%
Q4 2018$1,166,000
+58.4%
265,130
+270.8%
0.00%
Q3 2018$736,000
-4.5%
71,504
+33.0%
0.00%
Q2 2018$771,00053,7580.00%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$4,840,0007.97%
CHI Advisors LLC 790,805$1,139,0001.11%
New Leaf Venture Partners, L.L.C. 1,795,545$2,586,0000.78%
SECTORAL ASSET MANAGEMENT INC 1,519,174$2,188,0000.38%
Novo Holdings A/S 473,441$682,0000.12%
WEDBUSH SECURITIES INC 33,135$48,0000.01%
OXFORD ASSET MANAGEMENT LLP 100,000$144,0000.00%
WASATCH ADVISORS LP 254,449$366,0000.00%
Tower Research Capital LLC (TRC) 21,602$31,0000.00%
FIL Ltd 783,423$1,128,0000.00%
View complete list of UNUM THERAPEUTICS INC shareholders